ASND
Ascendis Pharma A/s
A Danish biopharmaceutical company that builds long-acting versions of existing medicines using its TransCon (transient conjugation) platform, which links a drug to a carrier molecule so it releases slowly in the body. Its approved products include Skytrofa for growth hormone deficiency and Yorvipath for hypoparathyroidism. Founded in Copenhagen in 2007 by entrepreneur Jan Møller Mikkelsen, the company takes its name from the Latin "ascendere," meaning "to climb."
ADRUnderlying: ASNDCUSIP: 04351P101HealthcareDK1 holder
Sponsored American Depositary Receipt representing ordinary shares
Total Value
$414.5K
Total Shares
1.8K
Net Share Change
+601
Activity
1 buying
Investor
Value
Shares
Weight
Change
